18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling

Donghui Cao; Zhifang Jia; Lili You; Yanhua Wu; Zhen Hou; Yueer Suo; Houjun Zhang; Simin Wen; Tetsuya Tsukamoto; Masanobu Oshima; Jing Jiang; Xueyuan Cao

doi:10.18632/oncotarget.12443

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling

Donghui Cao, Zhifang Jia, Lili You, Yanhua Wu, Zhen Hou, Yueer Suo, Houjun Zhang, Simin Wen, Tetsuya Tsukamoto, Masanobu Oshima, Jing Jiang and Xueyuan Cao _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:71960-71973. https://doi.org/10.18632/oncotarget.12443

Metrics: PDF 2476 views | HTML 2942 views | ?

Abstract

Donghui Cao1, Zhifang Jia1, Lili You1, Yanhua Wu1, Zhen Hou2, Yueer Suo2, Houjun Zhang2, Simin Wen1, Tetsuya Tsukamoto3, Masanobu Oshima4, Jing Jiang1, Xueyuan Cao2

1Division of Clinical Research, First Hospital of Jilin University, Changchun, Jilin 130021, China

2Department of Gastric and Colorectal Surgery, First Hospital of Jilin University, Changchun, Jilin 130021, China

3Department of Diagnostic Pathology I, School of Medicine, Fujita Health University, Toyoake, 470-1192, Japan

4Cancer Research Institute, Kanazawa University, Kanazawa, 920-1192, Japan

Correspondence to:

Jing Jiang, email: [email protected]

Xueyuan Cao, email: [email protected]

Keywords: 18β-glycyrrhetinic acid, gastric cancer, COX-2, miR-149-3p, Wnt-1

Received: May 05, 2016 Accepted: September 24, 2016 Published: October 04, 2016

ABSTRACT

18β-glycyrrhetinic acid (GRA) exerts anti-tumor effects on various types of cancer. In the present study, we found that GRA attenuated the severity of gastritis and suppressed gastric tumorigenesis in transgenic mice. We also discovered that miR-149-3p was downregulated in gastric cancer tissues and cell lines as compared to normal gastric tissues and epithelial cells, but was upregulated by GRA. miR-149-3p expression also correlated negatively with lymphnode metastasis. Our functional assays showed that miR-149-3p overexpression inhibited cell proliferation and cell cycle progression while inducing apoptosis, while inhibition of miR-149-3p had the opposite effects. In addition, we identified Wnt-1 as a direct target of miR-149-3p. These data suggest that GRA inhibits the initiation and progression of gastric tumors by ameliorating the inflammatory microenvironment through downregulation of COX-2 expression and by inhibiting Wnt-1 expression through the upregulation of tumor suppressor miR-149-3p. GRA may thus have the potential to serve as a useful therapeutic agent for the prevention and treatment of gastric cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 12443

Publication Alerts

Research Papers:

18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling

Abstract